检索
AI 对话
AI 写作
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Oral elacestrant vs standard-of-care in estrogen receptor-positive, HER2-negative (ER+/HER2-) advanced or metastatic breast cancer (mBC) without detectable ESR1 mutation (EMERALD): Subgroup analysis by prior duration of CDK4/6i plus endocrine therapy (ET)

Virginia G. Kaklamani,Francois Clement Bidard,Patrick Neven,Alberto J. Montero,Marie-Ange Mouret-Reynier,Joohyuk Sohn, Donatienne Taylor,Frederic Forget,Kathleen Kiernan Harnden,Hung T. Khong, Judit Kocsis,Florence Dalenc,Patrick Michael Dillon,Simon Waters,Jose A. Garcia-Saenz,Philippe Georges Aftimos,Javier Cortes,Simona Scartoni, Nassir Habboubi,Aditya Bardia

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要